• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙门氏菌中氟喹诺酮敏感性降低的检测及萘啶酸筛选试验的验证

Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.

作者信息

Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P

机构信息

Antimicrobial Research Laboratory, National Public Health Institute, Turku University, Turku, Finland.

出版信息

J Clin Microbiol. 1999 Nov;37(11):3572-7. doi: 10.1128/JCM.37.11.3572-3577.1999.

DOI:10.1128/JCM.37.11.3572-3577.1999
PMID:10523554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC85694/
Abstract

We evaluated 1,010 Salmonella isolates classified as fluoroquinolone susceptible according to the National Committee for Clinical Laboratory Standards guidelines for susceptibility to nalidixic acid and three fluoroquinolones. These isolates were divided into two distinct subpopulations, with the great majority (n = 960) being fully ciprofloxacin susceptible and a minority (n = 50) exhibiting reduced ciprofloxacin susceptibility (MICs ranging between 0.125 and 0.5 microg/ml). The less ciprofloxacin-susceptible isolates were uniformly resistant to nalidixic acid, while only 12 (1.3%) of the fully susceptible isolates were nalidixic acid resistant. A similar association was observed between resistance to nalidixic acid and decreased susceptibility to ofloxacin or norfloxacin. A mutation of the gyrA gene could be demonstrated in all isolates for which the ciprofloxacin MICs were >/= 0.125 microg/ml and in 94% of the nalidixic acid-resistant isolates but in none of the nalidixic acid-susceptible isolates analyzed. Identification of nalidixic acid resistance by the disk diffusion method provided a sensitivity of 100% and a specificity of 87.3% as tools to screen for isolates for which the MICs of ciprofloxacin were >/= 0.125 microg/ml. We regard it as important that microbiology laboratories endeavor to recognize these less susceptible Salmonella strains, in order to reveal their clinical importance and to survey their epidemic spread.

摘要

我们根据美国国家临床实验室标准委员会关于萘啶酸和三种氟喹诺酮类药物敏感性的指南,对1010株被分类为对氟喹诺酮敏感的沙门氏菌分离株进行了评估。这些分离株被分为两个不同的亚群,绝大多数(n = 960)对环丙沙星完全敏感,少数(n = 50)对环丙沙星的敏感性降低(MIC范围在0.125至0.5微克/毫升之间)。对环丙沙星敏感性较低的分离株对萘啶酸均耐药,而完全敏感的分离株中只有12株(1.3%)对萘啶酸耐药。在对萘啶酸耐药和对氧氟沙星或诺氟沙星敏感性降低之间也观察到了类似的关联。在所有环丙沙星MIC≥0.125微克/毫升的分离株以及94%对萘啶酸耐药的分离株中都能检测到gyrA基因突变,但在所分析的对萘啶酸敏感的分离株中均未检测到。通过纸片扩散法鉴定萘啶酸耐药性,作为筛选环丙沙星MIC≥0.125微克/毫升分离株的工具,其敏感性为100%,特异性为87.3%。我们认为微生物实验室努力识别这些敏感性较低的沙门氏菌菌株很重要,以便揭示它们的临床重要性并调查其流行传播情况。

相似文献

1
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.沙门氏菌中氟喹诺酮敏感性降低的检测及萘啶酸筛选试验的验证
J Clin Microbiol. 1999 Nov;37(11):3572-7. doi: 10.1128/JCM.37.11.3572-3577.1999.
2
Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.萘啶酸耐药性对检测环丙沙星敏感性降低的沙门氏菌的预测价值。
Int J Antimicrob Agents. 2004 Apr;23(4):332-6. doi: 10.1016/j.ijantimicag.2003.09.014.
3
Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.萘啶酸筛选对氟喹诺酮耐药伤寒沙门氏菌的有效性。
J Coll Physicians Surg Pak. 2006 Jan;16(1):31-4.
4
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.用于检测大肠杆菌中gyrA基因突变的快速检测方法的开发以及从复杂性尿路感染患者分离的临床菌株中gyrA基因突变发生率的测定。
J Clin Microbiol. 1997 Sep;35(9):2315-9. doi: 10.1128/jcm.35.9.2315-2319.1997.
5
Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.阴沟肠杆菌喹诺酮耐药临床分离株中gyrA和parC基因突变的检测
J Antimicrob Chemother. 1997 Oct;40(4):543-9. doi: 10.1093/jac/40.4.543.
6
Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.从土耳其人类中分离出的对环丙沙星敏感性降低的沙门氏菌菌株对萘啶酸的耐药性
Jpn J Infect Dis. 2006 Apr;59(2):117-9.
7
Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.鼠伤寒沙门氏菌耐萘啶酸临床分离株中喹诺酮耐药机制的分析
J Med Microbiol. 1997 Jul;46(7):623-8. doi: 10.1099/00222615-46-7-623.
8
Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.从英国动物中分离出的耐萘啶酸沙门氏菌血清型的gyrA和parC基因中的突变作用。
J Antimicrob Chemother. 1998 Jun;41(6):635-41. doi: 10.1093/jac/41.6.635.
9
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.肠炎沙门氏菌中的新型喹诺酮耐药现象:对萘啶酸敏感但对氟喹诺酮敏感性降低的分离株
J Clin Microbiol. 2005 Nov;43(11):5775-8. doi: 10.1128/JCM.43.11.5775-5778.2005.
10
High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.大肠杆菌及其他肠杆菌科细菌临床分离株中耐萘啶酸、对环丙沙星敏感表型的高流行率。
Diagn Microbiol Infect Dis. 2002 Apr;42(4):257-61. doi: 10.1016/s0732-8893(01)00357-1.

引用本文的文献

1
Dogs fed raw meat-based diets are vectors of drug-resistant Salmonella infection in humans.食用以生肉为主食的狗是人类耐药性沙门氏菌感染的传播媒介。
Commun Med (Lond). 2025 Jun 4;5(1):214. doi: 10.1038/s43856-025-00919-2.
2
Nalidixic acid-a good marker of fluoroquinolone resistance mechanisms in .萘啶酸——用于(此处原文不完整,推测为某种细菌或微生物中氟喹诺酮耐药机制的良好标志物)
Microbiol Spectr. 2025 Jul;13(7):e0197424. doi: 10.1128/spectrum.01974-24. Epub 2025 May 22.
3
The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China.中国河南省鼠伤寒沙门氏菌血清型肠炎亚种的表型和耐药分子特征。
BMC Infect Dis. 2020 Jul 15;20(1):511. doi: 10.1186/s12879-020-05203-3.
4
Systematic Evaluation of Whole Genome Sequence-Based Predictions of Serotype and Antimicrobial Resistance.基于全基因组序列的血清型和抗菌药物耐药性预测的系统评价
Front Microbiol. 2020 Apr 3;11:549. doi: 10.3389/fmicb.2020.00549. eCollection 2020.
5
Reply to Chu et al., "Adoption of the New CLSI Fluoroquinolone Breakpoints for ".对朱等人《采用新的临床和实验室标准协会(CLSI)氟喹诺酮类药物折点用于……》的回复
J Clin Microbiol. 2019 Oct 23;57(11). doi: 10.1128/JCM.01268-19. Print 2019 Nov.
6
Transferable Mechanisms of Quinolone Resistance from 1998 Onward.1998 年以来喹诺酮类耐药的可转移机制。
Clin Microbiol Rev. 2019 Aug 14;32(4). doi: 10.1128/CMR.00007-19. Print 2019 Sep 18.
7
Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015.描述 2000-2015 年拉丁美洲志贺菌属种的分布特征以及对环丙沙星和萘啶酸的药敏性。
PLoS One. 2019 Aug 2;14(8):e0220445. doi: 10.1371/journal.pone.0220445. eCollection 2019.
8
High prevalence of fluoroquinolone-resistant Escherichia coli strains isolated from urine clinical samples.从尿液临床样本中分离出的耐氟喹诺酮大肠杆菌菌株的高流行率。
J Prev Med Hyg. 2019 Mar 29;60(1):E25-E30. doi: 10.15167/2421-4248/jpmh2019.60.1.884. eCollection 2019 Mar.
9
Quinolones Losing Favour in Enteric Fever.喹诺酮类药物在伤寒治疗中失宠。
Med J Armed Forces India. 2005 Jul;61(3):308. doi: 10.1016/S0377-1237(05)80200-X. Epub 2011 May 30.
10
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.用于检测耐氟喹诺酮类肠炎沙门氏菌的培氟沙星纸片扩散法的建立
J Clin Microbiol. 2015 Nov;53(11):3411-7. doi: 10.1128/JCM.01287-15. Epub 2015 Aug 19.

本文引用的文献

1
Reduced susceptibility to quinolones in Salmonella typhi acquired in Europe: a clinical failure of treatment.在欧洲获得的伤寒沙门氏菌对喹诺酮类药物敏感性降低:治疗的临床失败
Clin Microbiol Infect. 1997;3(5):576-577. doi: 10.1111/j.1469-0691.1997.tb00313.x.
2
Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones.由对氟喹诺酮类药物敏感性降低的伤寒杆菌菌株引起的伤寒热。
Clin Microbiol Infect. 1997;3(5):541-544. doi: 10.1111/j.1469-0691.1997.tb00304.x.
3
Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997.1995年至1997年期间芬兰沙门氏菌血清型中氟喹诺酮耐药性不断增加。
J Antimicrob Chemother. 1999 Jan;43(1):145-8. doi: 10.1093/jac/43.1.145.
4
Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg?染色体回旋酶基因突变导致的喹诺酮耐药性。这只是冰山一角吗?
J Antimicrob Chemother. 1998 Dec;42(6):683-8. doi: 10.1093/jac/42.6.683.
5
Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.从英国动物中分离出的耐萘啶酸沙门氏菌血清型的gyrA和parC基因中的突变作用。
J Antimicrob Chemother. 1998 Jun;41(6):635-41. doi: 10.1093/jac/41.6.635.
6
Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan.塔吉克斯坦出现耐环丙沙星伤寒沙门氏菌疫情。
Lancet. 1998 Jan 31;351(9099):339. doi: 10.1016/s0140-6736(05)78338-0.
7
Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996.1996年英格兰和威尔士致病性肠杆菌科细菌对环丙沙星的耐药性
J Clin Pathol. 1997 Dec;50(12):1027-8. doi: 10.1136/jcp.50.12.1027.
8
Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis.环丙沙星治疗侵袭性非伤寒沙门氏菌病失败。
Clin Infect Dis. 1998 Feb;26(2):535-6. doi: 10.1086/517087.
9
Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.越南耐喹诺酮伤寒沙门氏菌:耐药的分子基础及治疗的临床反应
Clin Infect Dis. 1997 Dec;25(6):1404-10. doi: 10.1086/516128.
10
DNA gyrase, topoisomerase IV, and the 4-quinolones.DNA 回旋酶、拓扑异构酶IV与4-喹诺酮类药物。
Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. doi: 10.1128/mmbr.61.3.377-392.1997.